Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmya for Symptomatic Uterine Fibroids (PEARL IV)
NCT01629563Phase 3Completed
- Sponsor
- PregLem
- Start
- Jun 2012
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of ulipristal in Uterine Fibroids (UF), sponsored by PregLem. Started Jun 2012; status: completed.
02
Drugs
ulipristal
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT01629563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01629563.